Skip to the main content.

Cell and Gene Therapy Series. Part 7 - Manufacturing Paradigms part II

Cell and Gene Blog Series: Part 7 - Future ATMP Manufacturing Paradigms

We wrap up this Cell and Gene series with a final blog - 7. Follow the link to continue learning about the future of ATMPs' manufacturing paradigm.

How our robotic isolator technology is setting a new standard for aseptic fill-finish

How our robotic isolator technology is setting a new standard for aseptic fill-finish

In the world of pharmaceutical manufacturing, our robotic isolator technology sets a new standard for aseptic fill-finish technology. By integrating...

Read More
Key Factors to Consider During the Design Process in Aseptic Manufacturing

Key Factors to Consider During the Design Process in Aseptic Manufacturing

Demand for the design and development of specialist aseptic manufacturing solutions is being driven by the significant growth in biological drug...

Read More
How patent expirations will reshape the Dry Powder Inhaler (DPI) Market?

How patent expirations will reshape the Dry Powder Inhaler (DPI) Market?

Over the next few years, a wave of patent expirations for leading inhaled therapies will fundamentally change the Dry Powder Inhaler (DPI) market....

Read More